Navigator Medicines operate as a biotech company.
Navigator Medicines has raised $100.0M in total funding. The most recent round was Series A. The last funding was announced in August 2024.
Navigator Medicines's investors include RA Capital Management, Forbion Capital Partners.
Navigator Medicines is headquartered in Scotch Plains, United States.
Navigator Medicines operate as a biotech company.
Navigator Medicines is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Navigator Medicines — Funding & Investors." VCBacked, August 27, 2024, https://www.vcbacked.co/company/navigator-medicines. Accessed September 29, 2026.
VCBacked. (2024). Navigator Medicines — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/navigator-medicines
{{cite web |title=Navigator Medicines — Funding & Investors |url=https://www.vcbacked.co/company/navigator-medicines |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated